Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates - Wikidata - awgldk - TriplyDB

Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates

Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates

http://www.wikidata.org/entity/Q28361132

about

Effect of a single 3'-methylene phosphonate linkage on the conformation of an A-DNA octamer double helix Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates Solid-Phase Supports for Oligonucleotide Synthesis Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity.Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.A monoclonal antibody extends the half-life of an anti-HIV oligodeoxynucleotide and targets it to CD4+ cells.Antiviral therapy for human immunodeficiency virus infections DNA and RNA derivatives to optimize distribution and delivery Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.Antisense agents in cancer research and therapeutics.Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligodeoxynucleotides.Innovations in the use of antisense oligonucleotides.Concepts and trends in antiviral chemotherapy in the period of AIDS: a review.Design and development of antisense drugs.5'-,3'-inverted thymidine-modified antisense oligodeoxynucleotide targeting midkine. Its design and application for cancer therapy.Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application.Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense.Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.Deprotection of methylphosphonate oligonucleotides using a novel one-pot procedure.Synthesis and base-pairing properties of the nuclease-resistant alpha-anomeric dodecaribonucleotide alpha-[r(UCUUAACCCACA)]Regiospecific inhibition of DNA duplication by antisense phosphate-methylated oligodeoxynucleotides Treatment of AIDS with drugs targeted to inhibit different stages of the HIV life cycle.'Hairpin' catalytic RNA model: evidence for helices and sequence requirement for substrate RNA.Sequence dependent effects in methylphosphonate deoxyribonucleotide double and triple helical complexes.The application of the AMB protective group in the solid-phase synthesis of methylphosphonate DNA analogues.Number and distribution of methylphosphonate linkages in oligodeoxynucleotides affect exo- and endonuclease sensitivity and ability to form RNase H substrates RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.Lethal oxidative damage to human immunodeficiency virus by human recombinant myeloperoxidase.

P2860

Q27659299-0A7FEBE4-EAC1-48AE-BECC-A90B8D899FBA Q28323598-92694228-62E3-4504-9554-50B881CA337D Q28339853-6F10F9D3-0D52-4E42-81A4-15A0DC82E9FD Q28355337-73A9559D-9ED3-4245-9DDD-40672E357F65 Q28359555-701BCB14-6B9B-470F-89AA-D287B597AA8F Q28378692-7B61FA32-E622-46B2-A163-F2C5BCD19608 Q29999315-90567A41-0A3C-41CB-B76C-91BDE1ABF07F Q31009736-CD78F3DC-8136-4152-A723-6141DA409591 Q33563974-B42D5BF4-0F30-4DDD-8740-2FE1C414AD7C Q34076980-C5C2C6D3-3D70-4EA3-816A-D9666C087366 Q34780339-92853EB3-E5E8-4D98-8C70-D86C0A4735F9 Q35366050-B3AF8885-7D3A-42C0-BD24-F60EF53DFAEA Q35858691-97EC2826-9F78-4C67-9F35-7E3FBA4A48DB Q36654713-811A73F9-9D32-49DC-8702-CAACF9294A11 Q37220809-EC12055C-ED42-4B54-81F6-E185E9B6CF33 Q37313430-96E26C76-B990-463D-9D46-795A8E1E9E22 Q37585661-7D8F6DD8-6548-46BA-9D4F-000BFD1FA7D2 Q37696968-63812BD3-C317-437A-9420-273EAD56E5E1 Q37783034-AD5B5BD2-B25C-4C81-B0C8-5388CC0F539A Q37937195-D15520D5-170A-470F-8742-F5CBF924ED2D Q38089175-6A41ED91-4687-49FB-BB5D-5D0F448EDC7D Q38290099-64E0D660-0E8E-44D5-A3C5-61F43F8FCD8A Q38313512-5044516A-6966-478F-81D7-6A67BF47951D Q38329856-559B49BC-C027-4D34-AB82-CA93904B1095 Q38334658-125A7A90-F7CA-4875-92A6-0C6CE4DC1C73 Q38349283-BFCB3304-ED53-4ED8-B8D3-F3CB98E33E78 Q40406767-37DD91A1-B0D5-4CD5-B236-5436B2F2842C Q40421057-9050DFED-B130-41D1-B0D4-EE17454DB2B1 Q40450702-3478631A-021F-46A9-83B7-02B1BF4A7B91 Q40468453-BD13ED41-9A16-49F3-82C7-3953437EB332 Q40513852-4C648BF6-87EA-47FD-8646-631173E7EC21 Q40517590-6142E8B7-3D8B-48EA-B2EF-FC4256E38C3E Q40519835-0D8E328B-FF94-4B76-B928-D49B6F447C11 Q40537453-19690275-AB7E-4A4C-8FF4-4E9B8C7AFDAE Q40539121-05D40B22-42B3-4E40-97D0-6CA194DC0FAE Q41623881-FD37B922-7483-4421-8D4D-68A1BDCDC507

P2860

Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates

http://www.wikidata.org/entity/Q28361132

description

1988 nî lūn-bûn

@nan

1988 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@ast

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@en

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@nl

type

label

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@ast

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@en

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@nl

prefLabel

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@ast

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@en

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@nl

P1433

Q28361132-C6520451-B53D-49CF-B7D0-F09A79E54135

P1476

Q28361132-051A9BE4-B25B-432E-B0F7-4DCAC266A339

P2093

Q28361132-251273C9-9A0E-4D5E-830A-8346BB60B4AC

Q28361132-2BCAB3E3-AC90-4929-A76C-E7377EAC4A6B

Q28361132-7BF94E95-D386-4832-AF18-689DDE35D330

Q28361132-B3E2147F-8FC4-40EF-B34A-18D77581EEAD

Q28361132-BA28286B-E26A-4786-9D54-3A68BF1B142F

Q28361132-D246AFDF-176D-4B65-AB0C-FCDFE8202FA4

P2860

Q28361132-0619D68D-CB3E-414F-AAEB-256362168708

Q28361132-131EB3B4-2947-4A21-AF68-51C595A23A1D

Q28361132-1B3CF6F0-2027-43E3-A321-77E309559F31

Q28361132-27FB7A6F-1808-4180-BFCD-323A96192760

Q28361132-30DE73B0-6E1A-4B05-97EC-444C07AD5EFD

Q28361132-365228C6-D66A-48D0-BA54-8E6E0568CFE1

Q28361132-36A794B0-F6E0-47CF-AB7E-889D4F803919

Q28361132-36B5D9E2-83A0-4D7D-922B-7F1985FE2535

Q28361132-3DA6E62E-FDF4-4EC5-8DC8-DF0FE7D7AB46

Q28361132-4D12F926-DCD6-4D03-B693-A8A11AC8E58F

P304

Q28361132-FF16CB8B-A31A-4DF3-A3AC-68BD8B0B4A51

P31

Q28361132-19E3CF6F-77C6-4C02-B34C-7526CACD38EF

P356

Q28361132-210EC5A4-E84F-4B73-AAC1-4DB96E0DB999

P407

Q28361132-8C82EC1D-84FB-4EB5-A4E6-67DB76856399

P433

Q28361132-31740B3D-49EB-4834-9199-BBAFE489291B

P478

Q28361132-90CC56AB-F439-4472-99B6-1B578A180DD5

P577

Q28361132-7DFDE62E-3F63-47C9-8D0A-CF47D06E73AD

P5875

Q28361132-D6B8019E-14FB-4D31-BB62-BE508579E916

P698

Q28361132-80626C5B-8F75-43DF-A21D-E71EA61C808D

P932

Q28361132-A1934DCE-1A8B-4F27-9760-DDD2AFC01CB4

P356

PNAS.85.20.7448

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Inhibition of acquired immunod ...... ynucleoside methylphosphonates

@en

P2093

J Goodchild

http://www.w3.org/2001/XMLSchema#string

M P Civeira

http://www.w3.org/2001/XMLSchema#string

P C Zamecnik

http://www.w3.org/2001/XMLSchema#string

P S Sarin

http://www.w3.org/2001/XMLSchema#string

S Agrawal

http://www.w3.org/2001/XMLSchema#string

T Ikeuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of HTLV-III/LAV replication by foscarnet

Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.

Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site

Selective inhibition of the cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent

Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

P304

7448-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.85.20.7448

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

1988-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19980941

http://www.w3.org/2001/XMLSchema#string

P698

3174646

http://www.w3.org/2001/XMLSchema#string

P932

282208

http://www.w3.org/2001/XMLSchema#string